Background: Funders encourage lay-volunteer inclusion in research. There are controversy and resistance, given concerns of role confusion, exploratory methods, and limited evidence about what value lay-volunteers bring to research. This overview explores these areas.
| INTRODUCTION
The requirements for the planning of patient (or personal) and public involvement (PPI) in research has increased 1 to encourage research that is "with" or "by" members of the public and patients rather than "on," "to", "about", or "for" them. However, there is no standardized reporting for PPI which makes it difficult to identify in reports of research. Consistent reporting of the design, conduct, analysis, and interpretation of the PPI in clinical trials could facilitate reproducibility and reduce correctable error. 2, 3 However, many researchers lack PPI 4 training and experience. In addition, impaired communications between patients, clinicians, and researchers are well documented and may obstruct meaningful involvement. 5, 6 This systematic overview of systematic reviews was undertaken to gather research into a single document to identify available evidence and best practice for PPI in the design of clinical trials. 7 It summarizes what has been found and reported about PPI in clinical trials; identifies the context, methods, or processes that facilitate PPI. This review collates the perceptions of the influence of PPI on the research process, outcomes, dissemination of results; and promotes the uptake of effective strategies to improve PPI in research to reduce resource costs that might result from ineffectual PPI.
| Why it is important to do this overview
Research in this field varies in quality, scope, size, and focus, making a systematic overview a practical option. 8, 9 This enables comparison and critical appraisal of choices made in review selection and can collate, analyse, and interpret study results across the separate reviews.
| Research question
What can we learn from existing systematic reviews about involving the public and patients in the design of clinical trials in terms of: 
| Aim
To undertake a systematic overview of systematic reviews of the reporting of PPI in the design of clinical trials.
| Objectives
1. Identify existing systematic reviews that examine PPI in trials.
2. Critically appraise these reviews to assess their methodological quality.
3. Extract data from these reviews and use these data to describe how, and to what extent, the public and patients have been involved in trials (other than as participants).
Seek examples of what worked and what did not to identify good
practice.
Identify methods and areas of involvement with positive or nega-
tive effects on trial design 6. Identify research gaps in PPI and trials design.
7. Identify good practice in the reporting of PPI.
2 | METHODS
| Research for consideration
Systematic reviews and overviews published in any language that reviewed existing public or patient involvement in clinical trials (other than as participants) were eligible. The involvement could include but was not limited to, prioritization of the research question, involvement in the design or conduct of the trial, analysis, presentation of results, or dissemination of findings. A review could include quantitative or qualitative or mixed methods studies. Reviews of PPI in clinical trials were eligible if they searched a minimum two databases, appraised the included studies, provided summary findings, and included a synthesis of the data and the information retrieved. 10 
| Outcome measures
The outcomes of interest were PPI employed in clinical trials design, the impact of PPI on research design and the tensions, barriers, recommendations, and strategies relating to PPI as reported in the studies included in the reviews.
| Data sources and search strategy
The following databases were searched from 1995 until December (Table 5) were reviewed by the authors and a medical librarian and adapted for each database.
The PRESS checklist 11 was used to ensure inclusion of essential elements in the search strategy. Reference lists and search terms of reviews captured by the initial searches were searched for additional reviews and topic experts were contacted. We searched Prospero for protocols and followed up conference abstracts identified through the database search that met inclusion criteria to see if they had been subsequently published.
| Public involvement
Volunteers from the Cochrane Task Exchange and Empower-2-Go assisted with screening, data extraction, analysis, prioritizing what to report, and editing. The dissemination plan for the overview includes promotion via social media, presentation at conferences, and dissemination to patient advocacy groups. Volunteers were invited to co-create the plain language summary, review the paper for readability, and work collaboratively to build an infographic to represent the overview.
| Screening and selection of reviews
All citations were screened in RAYYAN, 12 a free online tool that allows the use of unlimited volunteers, tracking, and blind review. To improve screening accuracy, retrieved citations were screened by one author (AP) and then rescreened by her 4 weeks later. This method was described in a published review of systematic reviews of treatment for intracranial aneurysms. 13 A random sample of 6% of titles and abstracts was double screened. Full papers were retrieved for articles that appeared eligible or potentially eligible on the basis of their title and abstract, and for a 1% random sample of those judged to be ineligible to check for correct exclusion. 13 Reviewers were not blinded to author, institution, or journal.
| Full paper retrieval
Full papers were downloaded to a shared folder and de-duplicated in Mendeley, 14 where overview authors could write and share notes, and add questions and additional data. Two authors screened the retrieved full papers independently to match them against our eligibility criteria. Papers were categorized as include, exclude, or unsure.
Papers classified as unsure were discussed, and agreement at all stages was reached by consensus of three authors.
| Data extracted from included reviews
Two review authors independently extracted key data for included reviews, using a data extraction form in EPPI reviewer 15 that was piloted on a small sample of reviews. Data on public involvement in clinical trials design and preparation was extracted, covering exploration of roles, policy, impact, reporting, interventions, and theoretical frameworks. Relevant data about PPI were included even when the primary focus of the review was not PPI. Table 1 reports the type of review used for the research question as this influences the way the data were collected and how reviews might score in reporting quality checklists. All findings were reviewed and discussed by members of the author team until consensus was reached.
| Quality assessment
The CASP 16 checklists for systematic reviews 17 were used as a preliminary screening tool when assessing systematic reviews for eligibility. The first three questions are general and can be used to include or exclude the review. The NICE Quality Appraisal Guidelines for Qualitative Studies Appendix-H form 18 was used to determine whether the research question(s) and theory underpinning reviews were appropriate for the outcomes sought. The following domains were included when assessing quality: aims, methodology, search quality, recruitment, data collection, data analysis, reflexivity, ethical considerations, findings, and research contributions.
| Risk of bias
Confidence in the Evidence from Reviews of Qualitative Research (CERQual) 19, 20 was used to summarize confidence in the findings of the reviews of qualitative research. This is based on four components:
limitations of methodology, relevance to the research question, coherence, and the adequacy of the data presented. CerQual enables ratings of "high", "medium", "low", and "very low" (although this final rating was not needed because such reviews were not eligible). The starting point of "high confidence" reflects that each review finding is a reasonable representation of the question of interest and is downgraded if there are factors that would weaken this assumption. 19 After assessing all four components, authors agreed on overall confidence in each review finding and the relevance to our research.
NICE, CASP, risk of bias, conflict of interest, and CerQual (CQ)
were aggregated, and reviews were categorized as Low <10.5
Medium > 15 High >21 confidence. All measures were pre-specified prior to analysis. The scoring of each review is shown in Figure 2 .
| Thematic analysis
A strength, weakness, opportunity, and threat (SWOT) framework was used to analyse the findings and organize the data into themes and code them for analysis. This made it possible to identify and agree on methods and areas of involvement with positive or negative effect on trial design and to identify research gaps. The SWOT approach is used in health care research 21, 22 to help teams to analyse data individually and then reach consensus on how to present their findings.
| Descriptions of information presentation forms
We present a summary of each included study in PRISMA checklist is available in Appendix-3, Table 6 .
| Search report

Figure 1 uses a Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) flow diagram to outline the process of study selection. 23 Our search of 11 databases yielded a total of 9433 records. Three additional records were found by searching the reference lists of included reviews, one more was included from the EPPI Reviewer database and one review was identified by an expert in the field.
| Title and abstract screening
After de-duplication, 6090 records remained. To improve screening accuracy, retrieved citations were screened by one author (AP) and then rescreened by her 4 weeks later. This method was described in a published review of systematic reviews of treatment for intracranial aneurysms. 13 A random sample of 6% of titles and abstracts were double screened by (AP and LA) and for a 1% random sample of those judged to be ineligible to check for correct exclusion. Full papers were retrieved for articles that appeared eligible or potentially eligible on the basis of their title and abstract. Reviewers were not blinded to author, institution, or journal. The agreement was 100% before discussion and 6051 records were excluded leaving n = 39 potentially eligible articles for full-text screening.
| Full-text screening
Two authors (LA and AP) independently checked the full text of n = 39 24-50 51-56 57-62 articles for eligibility, n = 12 51-56 57-62 of which were excluded. Reasons for exclusion were as follows: no public involvement in trials design [51] [52] [53] [54] [55] [56] (n = 6) and not a systematic review [57] [58] [59] [60] [61] [62] (n = 6). Twenty-seven reviews met inclusion criteria for data extraction and analysis (Appendix 2, Table 5 Excluded Studies).
Interrater agreement prior to discussion was Kappa = 0.862 (SE = 0.067, 95% CI = 0.732-0.992), and consensus was reached by discussion. 3.5 | Quality appraisal and methodological assessment of included reviews
| Included reviews
After the assessment of confidence in the findings for our review question by two reviewers and a lay volunteer, the included reviews were categorized as low 27, 36, 40, 43, 44, 47 (n = 6), moderate [24] [25] [26] [28] [29] [30] [31] [32] [33] [34] 38, 39, 45, 50 (n = 14), and high 35, 37, 41, 42, 46, 48, 49 (n = 7). Conflicts of interest and risk of bias were reported for the included studies 32,41,46,49 in four of the included reviews. In two reviews, this was referred to but not reported by individual study. 31, 49 As expected, although some reviews might have been good enough to answer their research question, they were a substandard source of evidence for our research question. For example, three scoping reviews 27, 31, 43 scored low on quality because they looked only at abstracts and case studies, but these still contained some useful information for our research questions. Likewise, studies seeking impact across research fields 28 contained valuable background information, but this was peripheral to the overview aim. The quantitative data reported was descriptive, heterogeneous, and scattered across reviews making it a poor fit for meta-analysis and of relatively little relevance to our overview.
| Extent of PPI involvement
PPI was more frequent in the form of researchers asking members of the public and patients for feedback on the trial design or citizen to citizen interaction such as moderating forums and recruiting participants, rather than in active participation for hands-on research tasks such as FIGURE 1 PRISMA flow diagram study design, ethical review, policy, recruiting, analysis, and dissemination. PPI impact was reported in 14 reviews using many formats. Four reviews [28] [29] [30] 40 written by authors working together on the question of impact investigated the reporting of impact and have proposed reporting guidelines; 61 however, these reviews were hampered by inconsistent reporting within individual studies. Figure 2 shows how PPI was reported across the reviews and the methods of public involvement for various tasks. It shows surveys and focus groups were dominant methods of involvement, yet all 27 reviews reported the use of multiple tasks and methods (Figure 3 ).
| Reviewers' use of PPI in their review
We recorded how review authors reported public involvement in their own reviews to supplement the inconsistent reporting of the numbers of studies or participants involved in tasks. This FIGURE 2 Quality appraisal using CASP, NICE, risk of bias (ROB)/conflict of interest (COI), and critical appraisal by CerQual (CQ) appraising four sectors; quality of methodology, coherence, relevance, and adequacy and reporting of bias or conflict of interest with scores each ranging from 1 to 3, low-high for a composite score of 21 information builds a unique value statement about whether talking about PPI encourages practice. Fourteen reviews did not report any PPI in the review, and activities were frequently passive. For example, the public was updated by review authors and then were invited to advise or comment on the review, rather than engaging the public directly with the data. This is shown in Figure 4 , where 11 reviews report the use of an advisory board. PPI extended to collaborative screening of the literature in three reviews, and analysis and study design roles were largely advisory as recorded in the multiple/other category with seven reviews. The reviews report lack of funding as a barrier to PPI, and two reviews reported offering compensation for PPI.
FIGURE 3 PPI in reviews (n = 27) grouped by task and method, RQ (research question), combination (multiple PPI tasks and methods reported), multiple/other refers to multiple tasks, and other methods such as peer to peer interviewing/support, administering interventions FIGURE 4 Number of included reviews (n = 27) and ways the review authors incorporated public involvement by task 3.8 | Our PPI for this systematic overview They co-created the plain language summary, suggested improvements for the tables and figures, reviewed the paper for readability, and will work collaboratively to build an infographic to represent the overview.
| Thematic analysis with review authors and citizen collaborators
In this section, we report what was learned from existing systematic reviews of primary research for involving the public and patients in the design of clinical trials through a SWOT analysis. This allowed us to code the narratives to answer our objectives ( Figure 5 ).
| Strengths of public involvement
Strengths were coded using themes of internal and external benefits. Twenty reviews contributed to these themes. Patients cite greater confidence, research literacy, hope, trust, and a sense of community. They felt participating gave their lives purpose, meaning, and identity. Patients also report learning more about their condition during trials, helping them to feel valued, empowered, and validated.
| External benefits
Consultation with volunteers contributed to salient, pragmatic study designs and raised issues that researchers would not otherwise have anticipated. Volunteers improved recruiting, interviews, influenced policy setting, and accessed funding for research. In addition, there was community influence where PPI was considered a factor in destigmatizing mental health, age issues, disease stereotypes, and cultural challenges.
The external benefits of PPI were reported from early stages in the design of a clinical trial, including in protocol consultation, setting userfocused research objectives, and finalizing research questions; developing questionnaires, interview schedules, and consent processes;
planning data analysis, user testing, and implementation and dissemination. Volunteers were also reported as helping with practical problem-solving skills, depth, and perspective.
PPI contributions to recruitment and follow-up timing, strategy, lay materials and protocols, funding applications, and research manuscripts were reported to increase relevance and add research value.
Progress was noted for research awareness, literacy, transparency, and training materials. This resulted in increased recruitment, retention, favourable policy integration, and community trust. These benefits were more frequent when there was bidirectional communication, collective decision-making, and research intervention delivery training available to support the volunteers.
| Weaknesses of public involvement
Weaknesses were coded by tensions and barriers. Shared tensions and barriers were followed by those specific to volunteers, researchers, and organizations. Ten reviews contributed to these themes. 24, 26, 29, 31, 33, 34, 37, 38, 41, 57 
| Tensions in public involvement
Shared tensions revolved around unclear roles, absent or ill-fitting reporting guidelines, tokenism, exclusion, framework limitations, FIGURE 5 SWOT themes for public involvement provides an outline of the SWOT with the themes used for analysis resource allocation, and administrative boundaries. Research questions posed by patients were not articulated in ways they could be applied.
Jargon was blamed for exclusion and confusion. Tensions were balanced by an overarching desire to carve out a mutually agreed path.
Volunteers reported needing early involvement to propose constructive changes. They welcomed frequent updates and specific feedback with opportunities for reflection and shared decision making about the fate of the research. Volunteers indicated that provision for their physical limitations was suboptimal. They worried about inappropriate conclusions from composite outcomes but lacked opportunity to share these concerns and noted they would benefit from research methods training.
Researchers worried about maintaining methodological rigour and focus while adapting research design for patients and report personal lobbying by volunteers for pet causes. Instances were reported where group dynamics changed and overly aggressive patients and those without respect for rules of confidentiality or data protection harmed the research. Researchers hesitated to involve people who were ill, who might slow the research pace, and compromise deadlines that might be related to funding.
Organizations reacted to potential "scope creep" where researchirrelevant community concerns increase costs, time, and threatened feasibility. Accountability was compromised when researchers added PPI in grants but failed to report this in research.
| Barriers to public involvement
Shared barriers included those imposed by cultures, values, and power hierarchies. There was limited co-creation of knowledge or community engagement for health via coalitions, collaborations, and partnerships.
Some trialists took positions that PPI was a specialist area and not scalable across research disciplines.
Patients reported that involving them too late in a trial meant that the design was already funded and fixed and that the priorities and outcomes were not reversible, leaving them with only user experience to contribute. They were vulnerable to negative attitudes or dismissive behaviour and felt overloaded when drawn into internal strife.
Researchers struggled to identify a lead for public involvement, a lack of relevant recruiting networks, difficulties with information about structured, practical methods of involvement, and insufficient time to plan for PPI.
Organizational or gatekeeper barriers ranged from concerns about data being hijacked by opinion rather being centred by evidence. Organizations struggled between tensions of protecting vulnerable patients and appearing paternalistic due to legal and ethical constraints.
| Opportunities for public involvement
Opportunities were represented by themes of recommendations and strategies. Nineteen reviews contributed to these themes. to reduce scheduling conflicts and manage costs. Reviews suggest engaging volunteers in post-study reflection.
| Suggestions
These suggestions were developed as a result of findings for good and bad practice in PPI, and all the included reviews contributed to this theme. PCORI USA, 65 (Tables 2 and 3 ).
| Threats to public involvement
Themes identified as threats are poor reporting, data contamination, ethical breaches, and bad practice. All included reviews contributed to this theme.
| Poor reporting
Threats centred around poor reporting and inadequate quality appraisal of studies and the absence of pre-study published protocols.
Conflicts of interest revolved around patient-provider relationships, industry, and undue influence of advocacy organizations.
| Ethical breaches
Volunteers reported fear to speak out due to threats of blacklisting or exclusion. Patients without training in ethics or research methods report feeling ill prepared to sit on ethics boards, decide policy, or provide good quality PPI because they may inadvertently breach confidentiality or patient safety. Cases of premature exposure of data on social media or prepublication leaks by volunteers were reported.
| Bad practice
Planning, training, and information deficits hindered volunteers' ability to contribute. Unpublished methods were lost opportunities for learning. Potential harms of PPI need to be balanced against potential benefits with the caveat that patients and carers might be vulnerable populations. Mixed methods studies without registered protocols could be used to pander influence or exalt experience above evidence. Methods could be tested by using a study within a trial (SWAT) 74 and reported for others to replicate, improve, and validate.
As patients become research collaborators, provide recruiting testimonials, conduct interviews with participants, and exert cultural change through social media declaring all conflicts of interest would be best practice. 75 However, standard conflict of interests declarations are insufficient to address relationships leading to unintentional bias or deliberate manipulation, as noted in an analysis of power relations and society/individual agency during research triangulation. 76 Disclosing prior roles between patients, researchers and referring clinicians can reduce the risk of bias 50 and identify indirect financial benefits in the form of industry influence 77 including medical device or intervention choices. 78 Agreed standardized declarations, started from protocol stages, introduced in reporting guidelines, and adopted by journal publishers may reduce the impact of conflicts of interest and bias, and increase reporting quality.
The overlap across reviews in impact appraisal, research prioritiza- 87 The deficits in standardized language, research methods and reporting of PPI provided challenges for identifying search terms, assessing quality and risk of bias and this impacted our interpretation of data and scope of comparisons for the overview.
| Differences between protocol and review
References in the protocol to quantitative methods, effect sizes, metaanalysis, GRADE, 88 and AMSTAR 89 were not relevant to the final systematic overview because all included reviews were reported qualitatively. We changed the emphasis to "value reported" rather than "impact reported" because the term impact was based on differing cultural assumptions across disciplines.
| CONCLUSIONS
PPI was wide-ranging and innovative in the reviews we identified.
Active public involvement in the decision-making process of designing trials was less common than consultation on what was already decided.
PPI initiated at the protocol stage was identified with best practice as was resource acquisition for training, planning, and compensation.
Involving lay volunteers for problem-solving provided insights peer review. The addition of patient reviewers by journals may contribute to health literacy and provide insights for future participatory research practice.
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